CA Patent

CA2563690C — Pharmaceutical compositions comprising intra- and extra- granular fractions

Assigned to Pharmascience Inc · Expires 2014-10-07 · 12y expired

What this patent protects

A pharmaceutical composition comprising a pharmaceutically acceptable active component and a pharmaceutically acceptable excipient component. The excipient component comprises a dissolution modifying excipient element. The composition is characterized in that the composition (i.e…

USPTO Abstract

A pharmaceutical composition comprising a pharmaceutically acceptable active component and a pharmaceutically acceptable excipient component. The excipient component comprises a dissolution modifying excipient element. The composition is characterized in that the composition (i.e. the excipient component) is at least substantially surfactant free (i.e. free or substantially free of surfactant).

Drugs covered by this patent

Patent Metadata

Patent number
CA2563690C
Jurisdiction
CA
Classification
—
Expires
2014-10-07
Drug substance claim
No
Drug product claim
No
Assignee
Pharmascience Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.